Bear did yeoman's works, analyzing projected event rates...and came up with an estimation of Sept/Oct for the FA, but that was when the FA was due at 125 events, 50% of the 250 total.  Now we're told it could be as high as 75%, which brings the total to 187.5....I don't know if its possible to have half a heart attack, stroke or to half die....

I'm a big fan of clear concise language....its that old, "mean what you say, say what you mean" thing.  Almost 2 months ago, on July 25th, the company announced FDA approval for the inclusion of USA patients in BETonMACE.  Here's what the PR said specifically:

Resverlogix has agreed to make adjustments to the existing BETonMACE study protocol and to update the Investigator's Brochure and the Informed Consent Documents.

So they've agreed to make adjustments....but we don't what the adjustments are.  As Clayton confirmed to me in an email asking what the adjustments are (were), they hadn't even been approved yet.  That's assuming Clayon has his facts straight. Here's what he said to me in an email a couple days later on July 27th.

Good afternoon

I have a request into our clinical group with respect to your question.

The updated protocol will be made available on www.clinicaltrials.gov when completed and approved.

Regards,

Clayton

So it seems they agreed to make adjustments, but at the time they announced it they hadn't approved them yet....ugh.

To recap....we're speculating that some form of financing (possibly a CVR or not) could be contigent on a thumbs up on Futility. But we now don't know at what point the FA will be done....125 events, 187.5....somewhere in between?  And we're still waiting for the adjustments to the BETonMACE protocol that they said they'd agreed to back on July 25th.  

Not much to do but sit back and wait on the next poorly written and confusing piece of news I guess.  Science strives for precision....I wish they strived for precision with their communications.